These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16170050)

  • 1. Experimental screening of dihydrofolate reductase yields a "test set" of 50,000 small molecules for a computational data-mining and docking competition.
    Elowe NH; Blanchard JE; Cechetto JD; Brown ED
    J Biomol Screen; 2005 Oct; 10(7):653-7. PubMed ID: 16170050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual ligand screening against Escherichia coli dihydrofolate reductase: improving docking enrichment using physics-based methods.
    Bernacki K; Kalyanaraman C; Jacobson MP
    J Biomol Screen; 2005 Oct; 10(7):675-81. PubMed ID: 16170049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using extended-connectivity fingerprints with Laplacian-modified Bayesian analysis in high-throughput screening follow-up.
    Rogers D; Brown RD; Hahn M
    J Biomol Screen; 2005 Oct; 10(7):682-6. PubMed ID: 16170046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the high-throughput screening computations.
    Lang PT; Kuntz ID; Maggiora GM; Bajorath J
    J Biomol Screen; 2005 Oct; 10(7):649-52. PubMed ID: 16170047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for dihydrofolate reductase inhibitors using MOLPRINT 2D, a fast fragment-based method employing the naïve Bayesian classifier: limitations of the descriptor and the importance of balanced chemistry in training and test sets.
    Bender A; Mussa HY; Glen RC
    J Biomol Screen; 2005 Oct; 10(7):658-66. PubMed ID: 16170051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-QSAR studies on the inhibitory activity of trimethoprim analogues against Escherichia coli dihydrofolate reductase.
    Vijayaraj R; Devi ML; Subramanian V; Chattaraj PK
    Chem Biol Drug Des; 2012 Jun; 79(6):935-42. PubMed ID: 22304783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased substrate affinity in the Escherichia coli L28R dihydrofolate reductase mutant causes trimethoprim resistance.
    Abdizadeh H; Tamer YT; Acar O; Toprak E; Atilgan AR; Atilgan C
    Phys Chem Chem Phys; 2017 May; 19(18):11416-11428. PubMed ID: 28422217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CoMFA and CoMSIA analyses of Pneumocystis carinii dihydrofolate reductase, Toxoplasma gondii dihydrofolate reductase, and rat liver dihydrofolate reductase.
    Gangjee A; Lin X
    J Med Chem; 2005 Mar; 48(5):1448-69. PubMed ID: 15743188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach.
    Parenti MD; Pacchioni S; Ferrari AM; Rastelli G
    J Med Chem; 2004 Aug; 47(17):4258-67. PubMed ID: 15293997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2.13 A structure of E. coli dihydrofolate reductase bound to a novel competitive inhibitor reveals a new binding surface involving the M20 loop region.
    Summerfield RL; Daigle DM; Mayer S; Mallik D; Hughes DW; Jackson SG; Sulek M; Organ MG; Brown ED; Junop MS
    J Med Chem; 2006 Nov; 49(24):6977-86. PubMed ID: 17125251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions.
    Cody V; Pace J; Chisum K; Rosowsky A
    Proteins; 2006 Dec; 65(4):959-69. PubMed ID: 17019704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of the inhibition of bovine liver dihydrofolate reductase by tea catechins: origin of slow-binding inhibition and pH studies.
    Navarro-Perán E; Cabezas-Herrera J; Hiner AN; Sadunishvili T; García-Cánovas F; Rodríguez-López JN
    Biochemistry; 2005 May; 44(20):7512-25. PubMed ID: 15895994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening.
    Wyss PC; Gerber P; Hartman PG; Hubschwerlen C; Locher H; Marty HP; Stahl M
    J Med Chem; 2003 Jun; 46(12):2304-12. PubMed ID: 12773035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary neutron diffraction studies of Escherichia coli dihydrofolate reductase bound to the anticancer drug methotrexate.
    Bennett BC; Meilleur F; Myles DA; Howell EE; Dealwis CG
    Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):574-9. PubMed ID: 15858267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary in vitro studies on two potent, water-soluble trimethoprim analogues with exceptional species selectivity against dihydrofolate reductase from Pneumocystis carinii and Mycobacterium avium.
    Forsch RA; Queener SF; Rosowsky A
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1811-5. PubMed ID: 15026078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity in structure-based drug design: identification of a novel, selective inhibitor of Pneumocystis carinii dihydrofolate reductase.
    Gschwend DA; Sirawaraporn W; Santi DV; Kuntz ID
    Proteins; 1997 Sep; 29(1):59-67. PubMed ID: 9294866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of trimethoprim bound to dihydrofolate reductase--a deuterium NMR study.
    Yang QX; Huang FY; Lin TH; Gelbaum L; Howell EE; Huang TH
    Solid State Nucl Magn Reson; 1996 Dec; 7(3):193-201. PubMed ID: 9050157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Here be dragons: docking and screening in an uncharted region of chemical space.
    Brenk R; Irwin JJ; Shoichet BK
    J Biomol Screen; 2005 Oct; 10(7):667-74. PubMed ID: 16170052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
    Senkovich O; Schormann N; Chattopadhyay D
    Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.